Clinical Trials Browser

Digestive System Neoplasms × regorafenib × Gastrointestinal × Clear all

NCT06099821 2023-10-26

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Phase 2 Recruiting

Gastrointestinal

Digestive System Neoplasms